Prognostic significance of tumor oxygenation in humans.
暂无分享,去创建一个
[1] A. Giaccia,et al. Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] C. Koch,et al. The Km for Radiosensitization of Human Tumor Cells by Oxygen is Much Greater than 3 mmHg and is Further Increased by Elevated Levels of Cysteine , 2001, Radiation research.
[3] C. Coleman,et al. Clinical trials with hypoxic cell sensitizers: time to retrench or time to push forward? , 1984, International journal of radiation oncology, biology, physics.
[4] J. Knisely,et al. Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[5] S M Evans,et al. Detection of hypoxia in human squamous cell carcinoma by EF5 binding. , 2000, Cancer research.
[6] C. Koch. A thin-film culturing technique allowing rapid gas-liquid equilibration (6 sec) with no toxicity to mammalian cells. , 1984, Radiation research.
[7] G. Semenza,et al. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. , 2001, Cancer research.
[8] J R Griffiths,et al. BOLD MRI of human tumor oxygenation during carbogen breathing , 2001, Journal of magnetic resonance imaging : JMRI.
[9] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[10] J. Karp,et al. Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5 , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[11] Chapman Jd,et al. Hypoxic sensitizers--implications for radiation therapy. , 1979 .
[12] C. Koch,et al. Detection of individual hypoxic cells in multicellular spheroids by flow cytometry using the 2-nitroimidazole, EF5, and monoclonal antibodies. , 1996, International journal of radiation oncology, biology, physics.
[13] R. Pötter,et al. Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[14] C. Koch,et al. Radiosensitization of hypoxic tumor cells by dodecafluoropentane: a gas-phase perfluorochemical emulsion. , 2002, Cancer research.
[15] Anne Whitehead,et al. Meta-Analysis of Controlled Clinical Trials , 2002 .
[16] Hypoxic fraction determinations with the BA1112 rat sarcoma: variation within and among assay techniques. , 1984, Radiation research.
[17] A. Harris,et al. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] S M Evans,et al. Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode. , 2000, International journal of radiation oncology, biology, physics.
[19] David J. Yang,et al. Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma , 1996, European Journal of Nuclear Medicine.
[20] C. Koch,et al. Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules. , 1990, Biochemical pharmacology.
[21] C. Koch,et al. Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles , 2001, Cancer Chemotherapy and Pharmacology.
[22] N. Bleehen,et al. A clinical phase I toxicity study of Ro 03-8799: plasma, urine, tumour and normal brain pharmacokinetics. , 1986, The British journal of radiology.
[23] M. Lerman,et al. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. , 2001, Cancer research.
[24] A. Hanlon,et al. Hypoxic regions exist in human prostate carcinoma. , 1999, Urology.
[25] R. Gatenby,et al. Oxygen tension in human tumors: in vivo mapping using CT-guided probes. , 1985, Radiology.
[26] R. Hill,et al. A quantitative analysis of the reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer cell lines , 1999, British Journal of Cancer.
[27] John B. Shoven,et al. I , Edinburgh Medical and Surgical Journal.
[28] C. Aquino-Parsons,et al. Measuring hypoxia in solid tumours--is there a gold standard? , 2001, Acta oncologica.
[29] B. Fenton,et al. Quantification of tumour vasculature and hypoxia by immunohistochemical staining and HbO2 saturation measurements , 1999, British Journal of Cancer.
[30] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[31] P Vaupel,et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.
[32] S. Dische,et al. The clinical testing of Ro 03-8799--pharmacokinetics, toxicology, tissue and tumor concentrations. , 1984, International journal of radiation oncology, biology, physics.
[33] W. Kaelin,et al. The von Hippel-Lindau tumor suppressor gene. , 2001, Experimental cell research.
[34] J. D. Chapman,et al. Binding of 14C-misonidazole to hypoxic cells in V79 spheroids. , 1982, British Journal of Cancer.
[35] B. Garrecht,et al. The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole. , 1983, The British journal of radiology.
[36] J. Overgaard,et al. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[37] D. Nelson,et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. , 1993, Journal of the National Cancer Institute.
[38] F. Eschwège,et al. Intratumoral oxygen tension in metastatic melanoma , 1997, Melanoma research.
[39] Y Yonekura,et al. Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[40] C. Lowenstein,et al. Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis. , 2001, Cancer research.
[41] C. J. Gillespie,et al. Radiation-Induced Events and Their Time Scale in Mammalian Cells , 1981 .
[42] R. Hill,et al. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[43] T L Phillips,et al. Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. , 1993, Radiation research.
[44] P. Kristjansen,et al. Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro. , 2001, Neoplasia.
[45] S. Rosenberg,et al. The grading of soft tissue sarcomas results of a clinicohistopathologic correlation in a series of 163 cases , 1984, Cancer.
[46] Y. Fujibayashi,et al. Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[47] H. Lyng,et al. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. , 1997, The American journal of pathology.
[48] M. Varia,et al. A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[49] R. Fisher,et al. Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[50] G. Semenza,et al. Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. , 2000, Cancer.
[51] David E. Housman,et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.
[52] D. Hedley,et al. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[53] G L Rosner,et al. Pretreatment oxygenation profiles of human soft tissue sarcomas. , 1994, International journal of radiation oncology, biology, physics.
[54] P. Vaupel,et al. Heterogeneous oxygenation of rectal carcinomas in humans: a critical parameter for preoperative irradiation? , 1984, Advances in experimental medicine and biology.
[55] J. Henk,et al. RADIOTHERAPY AND HYPERBARIC OXYGEN IN HEAD AND NECK CANCER Interim Report of Second Clinical Trial , 1977, The Lancet.
[56] D. Hedley,et al. A comparison in individual murine tumors of techniques for measuring oxygen levels. , 1999, International journal of radiation oncology, biology, physics.
[57] Andreas Dietz,et al. Predictive Value of the Tumor Oxygenation by Means of pO2 Histography in Patients with Advanced Head and Neck Cancer , 2001, Strahlentherapie und Onkologie.
[58] P. Kolstad. Oxygen Tension and Radiocurability in Cancer of the Cervix , 1964, Acta obstetricia et gynecologica Scandinavica.
[59] W. Jelkmann,et al. Vascular endothelial growth factor gene expression in the human breast cancer cell line MX-1 is controlled by O2 availability in vitro and in vivo. , 2001, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.
[60] H. Lyng,et al. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. , 1998, British Journal of Cancer.
[61] A. Harris,et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. , 2001, Cancer research.
[62] J. Henk. Late results of a trial of hyperbaric oxygen and radiotherapy in head and neck cancer: a rationale for hypoxic cell sensitizers? , 1986, International journal of radiation oncology, biology, physics.
[63] P. Ratcliffe,et al. Activation of the HIF pathway in cancer. , 2001, Current opinion in genetics & development.
[64] A. Rauth,et al. Differences in the toxicity and metabolism of the 2-nitroimidazole misonidazole (Ro-07-0582) in HeLa and Chinese hamster ovary cells. , 1978, Cancer research.
[65] J. Overgaard. Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors. , 1994, Oncology research.
[66] M. Dewhirst,et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. , 1996, Cancer research.
[67] H. Lyng,et al. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[68] B. Galy,et al. Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. , 1999, The American journal of pathology.
[69] D. Bloch,et al. DNA damage measured by the comet assay in head and neck cancer patients treated with tirapazamine. , 1999, Neoplasia.
[70] D. P. Jones. Renal metabolism during normoxia, hypoxia, and ischemic injury. , 1986, Annual review of physiology.
[71] C. Koch,et al. 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors. , 1996, Cancer research.
[72] L. Harwell,et al. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. , 1993, Cancer research.
[73] A. Fyles,et al. Tumor size and oxygenation are independent predictors of nodal diseases in patients with cervix cancer. , 2001, International journal of radiation oncology, biology, physics.
[74] P Vaupel,et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[75] B. Movsas,et al. Marking Hypoxia in Rat Prostate Carcinomas with β-d-[125I]Azomycin Galactopyranoside and [99mTc]HL-91: Correlation with Microelectrode Measurements , 2001 .
[76] L. Giudice,et al. Regulation of insulin-like growth factor-binding protein-1 by nitric oxide under hypoxic conditions. , 2000, The Journal of clinical endocrinology and metabolism.
[77] C. Koch,et al. Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5. , 2002, Methods in enzymology.
[78] Rakesh K. Jain,et al. Vascular and interstitial barriers to delivery of therapeutic agents in tumors , 1990, Cancer and Metastasis Reviews.
[79] M. Wei,et al. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[80] A. Koong,et al. Pancreatic tumors show high levels of hypoxia. , 2000, International journal of radiation oncology, biology, physics.
[81] B. Teicher,et al. The hypoxic tumor cell: a target for selective cancer chemotherapy. , 1980, Biochemical pharmacology.
[82] T. Phillips,et al. Final report on the united states phase i clinical trial of the hypoxic cell radiosensitizer, misonidazole (RO‐07‐0582; NSC #261037) , 1981, Cancer.
[83] O. S. Nielsen,et al. Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations , 2001, British Journal of Cancer.
[84] B. Siim,et al. Tirapazamine-induced cytotoxicity and DNA damage in transplanted tumors: relationship to tumor hypoxia. , 1997, Cancer research.
[85] Henry Brem,et al. Drug delivery to tumors of the central nervous system , 2001, Current neurology and neuroscience reports.
[86] Jean Charles Gilbert,et al. Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[87] W. Curran,et al. Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[88] C. Koch,et al. Mapping of the vascular endothelial growth factor-producing hypoxic cells in multicellular tumor spheroids using a hypoxia-specific marker. , 1995, Cancer research.
[89] D. Schoenfeld,et al. Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas , 1983, Cancer.
[90] J. Overgaard,et al. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study. , 1989, International journal of radiation oncology, biology, physics.
[91] S. Evans,et al. Cysteine concentrations in rodent tumors: Unexpectedly high values may cause therapy resistance , 1996, International journal of cancer.
[92] M C Weissler,et al. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. , 1998, Cancer research.
[93] P. Olive,et al. The Range of Oxygenation in SiHa Tumor Xenografts , 2002, Radiation research.
[94] J. Fandrey,et al. Nitric oxide affects the production of reactive oxygen species in hepatoma cells: implications for the process of oxygen sensing. , 2000, Free radical biology & medicine.
[95] C. Koch,et al. Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors. , 1996, The Journal of pharmacology and experimental therapeutics.
[96] K. Kihara,et al. Regulation of vascular endothelial growth factor transcription by endothelial PAS domain protein 1 (EPAS1) and possible involvement of EPAS1 in the angiogenesis of renal cell carcinoma , 2001, Cancer.
[97] D. Batlle,et al. Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose. , 2001, Diabetes.
[98] B. Wouters,et al. Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. , 1997, Radiation research.
[99] C. Ling,et al. Interaction of misonidazole and oxygen in the radiosensitization of mammalian cells. , 1980, International journal of radiation oncology, biology, physics.
[100] G. Cruickshank,et al. Direct measurement of the PO2 distribution in human malignant brain tumours. , 1994, Advances in experimental medicine and biology.
[101] R K Jain,et al. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha--> hypoxia response element--> VEGF cascade differentially regulates vascular response and growth rate in tumors. , 2000, Cancer research.
[102] D J Terris,et al. Head and Neck Cancer: The Importance of Oxygen , 2000, The Laryngoscope.
[103] J. Rasey,et al. Comparison of binding of [3H]misonidazole and [14C]misonidazole in multicell spheroids. , 1985, Radiation research.
[104] S. Hahn,et al. Hypoxia in human intraperitoneal and extremity sarcomas. , 2001, International journal of radiation oncology, biology, physics.
[105] M Molls,et al. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. , 1999, International journal of radiation oncology, biology, physics.
[106] G. Semenza,et al. Expression of hypoxia‐inducible factor 1α in brain tumors , 2000 .
[107] C. Koch,et al. Hypoxic Heterogeneity in Human Tumors: EF5 Binding, Vasculature, Necrosis, and Proliferation , 2001, American journal of clinical oncology.
[108] D. M. Brown,et al. Factors influencing intracellular uptake and radiosensitization by 2-nitroimidazoles in vitro. , 1983, Radiation research.
[109] P. Olive,et al. Vascular endothelial growth factor expression is independent of hypoxia in human malignant glioma spheroids and tumours , 2000, British Journal of Cancer.
[110] C J Koch,et al. Enhanced radiation-sensitivity by preincubation with nitroimidazoles: effect of glutathione depletion. , 1994, International journal of radiation oncology, biology, physics.
[111] T K Lewellen,et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. , 1996, International journal of radiation oncology, biology, physics.
[112] M. Varia,et al. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. , 1997, International journal of radiation oncology, biology, physics.
[113] O. S. Nielsen,et al. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. , 1996, International journal of radiation oncology, biology, physics.
[114] A Dietz,et al. Repeatability and prognostic impact of the pretreatment pO(2) histography in patients with advanced head and neck cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[115] A. Fyles,et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[116] M Detmar,et al. Tumor angiogenesis. , 2000, The journal of investigative dermatology. Symposium proceedings.
[117] K. Groebe,et al. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids , 1995, International journal of cancer.
[118] A. Harris,et al. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. , 2001, Cancer research.
[119] P. Workman,et al. Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors. , 1994, International journal of radiation oncology, biology, physics.
[120] M. Lerman,et al. Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase. , 2002, Cancer research.
[121] J. Bussink,et al. Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas , 2000, British Journal of Cancer.
[122] J. Pastorek,et al. Expression of MaTu‐MN protein in human tumor cultures and in clinical specimens , 1993, International journal of cancer.
[123] M. W. D. Dvm. Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome , 1998 .
[124] M. Stratford,et al. Cellular uptake of misonidazole and analogues with acidic or basic functions. , 1985, International journal of radiation biology and related studies in physics, chemistry, and medicine.
[125] Johan Bussink,et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. , 2002, Cancer research.
[126] J. Kaanders,et al. ARCON: experience in 215 patients with advanced head-and-neck cancer. , 2001, International journal of radiation oncology, biology, physics.
[127] M. Dewhirst,et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. , 1997, International journal of radiation oncology, biology, physics.
[128] A. J. Varghese,et al. Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo. , 1976, Cancer research.
[129] P. Lambin,et al. Oxygenation of head and neck tumors , 1993, Cancer.
[130] M. Parliament,et al. Imaging tumor hypoxia and tumor perfusion. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[131] H. Lyng,et al. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis , 2000, British Journal of Cancer.
[132] L. Wiebe,et al. Nitroimidazole adducts as markers for tissue hypoxia: mechanistic studies in aerobic normal tissues and tumour cells. , 1992, British Journal of Cancer.
[133] J. Raleigh,et al. Marking hypoxic cells for complement and cytotoxic T lymphocyte-mediated lysis: using pimonidazole. , 1996, The British journal of cancer. Supplement.
[134] J. Ballinger,et al. Imaging hypoxia in tumors. , 2001, Seminars in nuclear medicine.
[135] H. Lyng,et al. Polarographic measurement of pO2 in cervix carcinoma. , 1997, Gynecologic oncology.
[136] A. Maity,et al. Hypoxia and VEGF mRNA expression in human tumors. , 2001, Neoplasia.
[137] M. Parliament,et al. Measurement of hypoxia in human tumours by non-invasive spect imaging of iodoazomycin arabinoside. , 1996, The British journal of cancer. Supplement.
[138] W. Sly,et al. Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. , 2001, The American journal of pathology.
[139] R. Sciot,et al. Hypoxia and perfusion measurements in human tumors--initial experience with pimonidazole and IUdR. , 2001, Acta oncologica.
[140] S M Evans,et al. Interlaboratory variation in oxygen tension measurement by Eppendorf “Histograph” and comparison with hypoxic marker , 1997, Journal of surgical oncology.
[141] C. J. Koch,et al. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. , 1987, British Journal of Cancer.
[142] M. Dewhirst,et al. MIBG inhibits respiration: potential for radio- and hyperthermic sensitization. , 1998, International journal of radiation oncology, biology, physics.
[143] P H Watson,et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. , 2000, Cancer research.
[144] D A Bloch,et al. Tissue oxygen distribution in head and neck cancer patients , 1999, Head & neck.
[145] N. Bleehen,et al. Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole). , 1988, International Journal of Radiation Oncology, Biology, Physics.